Current role
Biotechnology · Healthcare
Board Member
2026-03-31–present
David Shapiro, M.D.
Board Member
Design Therapeutics, Inc. (DSGN)Equibles does not estimate personal net worth.
Get an email with a short summary when Design Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DSGN alertsAbout David Shapiro, M.D.
David Shapiro, M.D. is recorded as Board Member at Design Therapeutics, Inc. (DSGN) since March 31, 2026. Design Therapeutics, Inc. reported in an 8-K filed April 1, 2026 that David Shapiro, M.D. was appointed Class III director, effective March 31, 2026. Design Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Design Therapeutics, Inc. includes Pratik Shah (CEO and Board Member), Pratik Shah, Ph.D. (CEO), Sean Jeffries (COO) and 7 others.
“On March 31, 2026, the Board appointed David Shapiro, M.D., to the Board as a Class III director, effective immediately, with a term ending at the Company’s 2027 annual meeting of stockholders.”
Affiliation history
-
Current
2026-03-31–present
Company network
Leadership on record at Design Therapeutics, Inc.
- Pratik Shah CEO, Board Member
- Pratik Shah, Ph.D. CEO
- Sean Jeffries COO
- Dawn Giangiulio Chief Accounting Officer
- Julie Burgess Chief Accounting Officer
- David Shapiro Board Member
- Heather Behanna, Ph.D Board Member
- Heather Berger Board Member
- John Schmid Board Member
- Justin Gover Board Member